| Descriptor English: | Parasympatholytics | ||||||
| Descriptor Spanish: |
Parasimpatolíticos
| ||||||
| Descriptor Portuguese: | Parassimpatolíticos | ||||||
| Descriptor French: | Parasympatholytiques | ||||||
| Entry term(s): |
Agent, Antispasmodic Agent, Parasympathetic-Blocking Agent, Parasympatholytic Agents, Antispasmodic Agents, Parasympathetic-Blocking Agents, Parasympatholytic Antispasmodic Antispasmodic Agent Antispasmodic Agents Antispasmodic Drug Antispasmodic Drugs Antispasmodic Effect Antispasmodic Effects Antispasmodics Drug, Antispasmodic Drug, Parasympatholytic Drugs, Antispasmodic Drugs, Parasympatholytic Effect, Antispasmodic Effect, Parasympatholytic Effects, Antispasmodic Effects, Parasympatholytic Parasympathetic Blocking Agent Parasympathetic Blocking Agents Parasympathetic-Blocking Agent Parasympathetic-Blocking Agents Parasympatholytic Parasympatholytic Agent Parasympatholytic Agents Parasympatholytic Drug Parasympatholytic Drugs Parasympatholytic Effect Parasympatholytic Effects Spasmolytic Spasmolytics |
||||||
| Tree number(s): |
D27.505.696.663.050.650 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D010276 | ||||||
| Scope note: | Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. |
||||||
| Annotation: | note entry term PARASYMPATHOLYTIC EFFECT: use only for the parasympatholyic effect of a chemical substance |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Public MeSH Note: | ANTISPASMODICS & SPASMOLYTICS were see MUSCLE RELAXANTS 1963-69 |
||||||
| Online Note: | use PARASYMPATHOLYTICS to search ANTISPASMODICS & SPASMOLYTICS 1970-76; use MUSCLES 1966-69 |
||||||
| History Note: | ANTISPASMODICS & SPASMOLYTICS were see MUSCLE RELAXANTS 1963-69 |
||||||
| Related: |
Anti-Ulcer Agents
MeSH Antiparkinson Agents MeSH Muscarinic Antagonists MeSH Muscle Relaxants, Central MeSH | ||||||
| DeCS ID: | 10465 | ||||||
| Unique ID: | D010276 | ||||||
| NLM Classification: | QV 132 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1960/01/01 | ||||||
| Date of Entry: | 1999/01/01 | ||||||
| Revision Date: | 2020/05/27 |
-
-
CHEMICALS AND DRUGS
Chemical Actions and Uses [D27]Chemical Actions and Uses
|
|
Parasympatholytics
- Preferred
Parasympatholytic Effect
- Related but not broader or narrower
Antispasmodic Effect
- Related but not broader or narrower
Antispasmodics
- Related but not broader or narrower
| Concept UI |
M0015923 |
| Scope note | Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. |
| Preferred term | Parasympatholytics |
| Entry term(s) |
Agent, Parasympathetic-Blocking Agent, Parasympatholytic Agents, Parasympathetic-Blocking Agents, Parasympatholytic Drug, Parasympatholytic Drugs, Parasympatholytic Parasympathetic Blocking Agent Parasympathetic Blocking Agents Parasympathetic-Blocking Agent Parasympathetic-Blocking Agents Parasympatholytic Parasympatholytic Agent Parasympatholytic Agents Parasympatholytic Drug Parasympatholytic Drugs |
| Concept UI |
M0556216 |
| Preferred term | Parasympatholytic Effect |
| Entry term(s) |
Effect, Parasympatholytic Effects, Parasympatholytic Parasympatholytic Effects |
| Concept UI |
M0556217 |
| Preferred term | Antispasmodic Effect |
| Entry term(s) |
Antispasmodic Effects Effect, Antispasmodic Effects, Antispasmodic |
| Concept UI |
M0015924 |
| Preferred term | Antispasmodics |
| Entry term(s) |
Agent, Antispasmodic Agents, Antispasmodic Antispasmodic Antispasmodic Agent Antispasmodic Agents Antispasmodic Drug Antispasmodic Drugs Drug, Antispasmodic Drugs, Antispasmodic Spasmolytic Spasmolytics |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
